CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Bacil Pharma Ltd

Bacil Pharma Ltd

BSE 524516 BACPHAR INE711D01018
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

26 filings · 9 material · busiest 2026-06-29 and 2026-07-09

What it files

General6 Board Outcome4 Board Meeting4 SAST4 Change in Management2 Results1 Compliance Certificate1 Fundraising1

Filings

26 in the window

  1. 25 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th August, 2026

    Outcome of Board Meeting held on 25th August, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  2. 25 August 2026

    General

    Appointment Of Director

    Appointment of Director

    Company Update / General View filing →

  3. 17 August 2026

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 25Th August 2026

    Bacil Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2026 ,inter alia, to consider and approve Board meeting to be held on 25th ....

    Board Meeting / Board Meeting View filing →

  4. 12 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August, 2026

    Outcome of Board Meeting held on 12th August, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  5. 12 August 2026

    Results

    Un-Audited Financial Results For The Quarter Ended 30Th June, 2026

    Un-audited Financial Results for the Quarter Ended 30th June, 2026

    Result / Financial Results View filing →

  6. 6 August 2026

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12Th August 2026

    Bacil Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting for ....

    Board Meeting / Board Meeting View filing →

  7. 28 July 2026

    General

    Announcement Under Regulation 30, LODR

    Regarding the incorporation of a wholly owned subsidiary of the company named Bacil Research & Development Private Limited.

    Company Update / General View filing →

  8. 14 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliance Certificate 74 (5) for the Quarter Ended 30th June, 2026

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  9. 10 July 2026

    Change in Management

    Change in Management

    Attached Resignation of Directors as query raised from BSE

    Company Update / Change in Management View filing →

  10. 9 July 2026

    Board Outcome

    524516 - Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    As Per Announcement

    Board Meeting / Outcome of Board Meeting View filing →

  11. 9 July 2026

    Fundraising

    Raising of Funds

    As Per Announcement

    Company Update / Raising of Funds View filing →

  12. 9 July 2026

    Change in Management

    Change in Management

    As Per Announcement

    Company Update / Change in Management View filing →

  13. 7 July 2026

    General

    Intimation Regarding Approval Of Name For Proposed Wholly-Owned Subsidiary

    Intimation regarding Approval of Name for Proposed Wholly-owned Subsidiary

    Company Update / General View filing →

  14. 3 July 2026

    Board Meeting

    Board Meeting Intimation for We Hereby Inform You That A Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Thursday, 9Th July 2026

    Bacil Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2026 ,inter alia, to consider and approve 1. The proposal for raising funds ....

    Board Meeting / Board Meeting View filing →

  15. 30 June 2026

    General

    Intimation For Appointment Of Independent Director

    Intimation for Appointment of Independent Director

    Company Update / General View filing →

  16. 29 June 2026

    SAST

    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Niraj Rajnikant Shah

    Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

  17. 29 June 2026

    Change in Directorate

    Change in Directorate

    Intimation of Appointment of Additional Non-Executive Independent Director

    Company Update / Change in Directorate View filing →

  18. 29 June 2026

    General

    Withdrawal Of Intimation For Appointment Of Independent Directors

    Withdrawal of Intimation for Appointment of Independent Directors

    Company Update / General View filing →

  19. 26 June 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On 26Th June, 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    As per Attached outcome of meeting

    Board Meeting / Outcome of Board Meeting View filing →

  20. 25 June 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Manubhai Shah

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  21. 25 June 2026

    Trading Window

    Closure of Trading Window

    Intimation of Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  22. 24 June 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nikita Hiren Patel

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  23. 23 June 2026

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Bacil Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/06/2026 ,inter alia, to consider and approve As per Attachment

    Board Meeting / Board Meeting View filing →

  24. 18 June 2026

    General

    Intimation Of Proposed Inc orporation Of Wholly-Owned Subsidiary

    Intimation of Proposed Inc orporation of Wholly-Owned Subsidiary

    Company Update / General View filing →

  25. 11 June 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nikita Patel

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  26. 5 June 2026

    Newspaper Publication

    Newspaper Publication

    Newsspaper Cutting for Financial Results

    Company Update / Newspaper Publication View filing →